NFE2L2 and cancer: Additionally, other strategies to induced NRF2 expression have been used in cancer such as somatic mutations in NRF2 (gain of function mutation) and epigenetic alterations in KEAP1 that leads to aberrant activation and nuclear translocation of NRF2 [104,105,106].